Serum Institute of India

Pune: The Serum Institute of India (SII) has said it will file a Rs 100-crore defamation suit against a Covishield vaccine trial participant for “malicious and misconceived” that he had…

Chennai: In a setback to the development of COVID-19 vaccines in India, a 40-year-old man has sent a legal notice to Serum Institute of India (SII) and others seeking Rs 5 crore in…

Pune: Serum Institute of India (SII) has decided to apply for emergency authorisation of COVID-19 vaccine in the next two weeks, chief executive Adar Poonawalla said on Saturday. The…

New Delhi: Prime Minister Narendra Modi will visit India’s three pharma majors on Saturday to personally review the development of COVID-19 vaccine and the manufacturing process. “As…

New Delhi: The Pune-based Serum Institute of India (SII) has said the COVID-19 vaccine developed by AstraZeneca and Oxford University is safe and effective, and the Indian trials are…

Pune: Prime Minister Narendra Modi will visit Pune-based Serum Institute of India (SII), which has partnered with global pharma giant AstraZeneca and Oxford University for a COVID-19 vaccine…

New Delhi: Every Indian will get vaccinated, probably by 2024, said Serum Institute of India’s (SII) CEO Adar Poonawalla. The Oxford COVID-19 vaccine will be priced at a maximum of Rs 1,000…

Pune: Serum Institute of India (SII) CEO Adar Poonawalla on Saturday raised some serious concerns regarding the production and distribution of COVID-19 vaccine in the country. Poonawalla…

Pune: The Serum Institute of India (SII) will start the third and final phase of human trial of Oxford-Astrazeneca’s coronavirus vaccine at Pune’s Sasson General Hospital early next week.…

New Delhi: A coronavirus vaccine will be available in the country by the beginning of next year, Union Health Minister Harsh Vardhan told the Rajya Sabha on Thursday. “Just like other…